Hypogammaglobulinemia, Acquired
2 clinical trials · Condition
◉ Watch Hypogammaglobulinemia, Acquired
| Record | Firm | Date |
|---|---|---|
| Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy (NCT06989541) | University of Alberta | 2025-06-01 |
| Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia (NCT06976476) | Memorial Sloan Kettering Cancer Center | 2025-05-08 |
Track Hypogammaglobulinemia, Acquired automatically
Every clearance here is in the API, with alerts when new ones post.